retatrutide clinical trial dosage Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) ESC 2024: Retatrutide improves lipid

A 2023 SELECT trial determined that patients with pre-existing cardiovascular disease who used Wegovy over 39.8 months experienced the following events, compared to patients given a placebo

Retatrutide: Designed to Last One of the newest GLP-1 medications in development is retatrutide , a triple agonist (GLP-1, GIP, and glucagon receptors) designed with an approximate 6-day half-life , thanks to advanced pharmaceutical engineering

Of course, there is stigma

Key GLP-1 Supportive Foods: Protein, Fiber & Healthy Fats Three main nutrient categories work particularly well with your body's GLP-1 system: protein, fiber, and healthy fats

Both cause sulfur burps in susceptible individuals